ONCOLife presents an exclusive interview with Dr. Miguel-Angel Perales, Co-Chair of the CAR T Vision initiative, as he shares ...

We’re honored to share our exclusive interview with Lorna Warick, CEO of Lymphoma Coalition. In this session, we explore the ...

About ONCOLife ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ...

South Rampart Pharma has announced promising results from its Phase 1 clinical trials for SRP-001, a non-opioid and non-hepatotoxic small molecule pain relief medication. Published in Scientific ...

ONCOLife presents an exclusive interview with Nick Slack, Chairman and CEO of The START Center for Cancer Research. In this session, we explore how the integration of the Carolina Urologic Research ...

Oncolytic viruses are emerging as a promising development in cancer treatment, not only destroying cancer cells but also modulating the tumor microenvironment to enhance immune responses. We had an ...

We are pleased to present an exclusive interview with Dana Brown, CEO and Chairman of the Board at iCAD Inc., to explore the future of breast cancer screening and the role of artificial intelligence ...

Antibody-Drug Conjugates (ADCs) are at the forefront of cancer treatment, providing targeted therapies with promising results for lung cancer. In this exclusive interview, we spoke with Dr. Maria de ...

The first AI-powered companion diagnostic for non-small cell lung cancer (NSCLC) has received FDA Breakthrough Device Designation. Developed by Roche, Ventana TROP2 RxDx Device combines ...